Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma
Clinical trial NCT04689659 · COMPLETED
Trial details
- NCT number
- NCT04689659
- Sponsor
- Beijing Boren Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2024-04-03
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.